Primary Carnitine Deficiency: Is Foetal Development Affected and Can Newborn Screening Be Improved?

Primary carnitine deficiency (PCD) causes low levels of carnitine in patients potentially leading to metabolic and cardiac symptoms. Newborn screening for PCD is now routine in many countries by measuring carnitine levels in infants. In this study we report Apgar scores, length and weight in newborn...

Full description

Bibliographic Details
Main Authors: Rasmussen, Jan, Hougaard, David M., Sandhu, Noreen, Fjællegaard, Katrine, Petersen, Poula R., Steuerwald, Ulrike, Lund, Allan M.
Format: Text
Language:English
Published: Springer Berlin Heidelberg 2017
Subjects:
Article
Faroe Islands
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680280/
http://www.ncbi.nlm.nih.gov/pubmed/28105570
https://doi.org/10.1007/8904_2016_30
Description
Summary:Primary carnitine deficiency (PCD) causes low levels of carnitine in patients potentially leading to metabolic and cardiac symptoms. Newborn screening for PCD is now routine in many countries by measuring carnitine levels in infants. In this study we report Apgar scores, length and weight in newborns with PCD and newborns born to mothers with PCD compared to controls. Furthermore we report how effective different screening algorithms have been to detect newborns with PCD in the Faroe Islands.

Similar Items